Literature DB >> 22544659

Candidate locus analysis for PHACE syndrome.

Sheri Mitchell1, Dawn H Siegel, Joseph T C Shieh, David A Stevenson, J Fredrik Grimmer, Tracey Lewis, Denise Metry, Ilona Frieden, Francine Blei, Hulya Kayserili, Beth A Drolet, Pinar Bayrak-Toydemir.   

Abstract

PHACE syndrome (OMIM #606519) is a neurocutaneous syndrome of unknown etiology and pathogenesis. We report on an individual with PHACE syndrome with a complete deletion of SLC35B4 on 7q33. In order to further analyze this region, SLC35B4 was sequenced for 33 individuals with PHACE syndrome and one parental set. Common polymorphisms with a possible haplotype but no disease causing mutation were identified. Sixteen of 33 samples of the PHACE syndrome patients were also analyzed for copy number variations using high-resolution oligo-comparative genomic hybridization (CGH) microarray. A second individual in this cohort had a 26.5 kb deletion approximately 80 kb upstream of SLC35B4 with partial deletion of the AKR1B1 on 7q33. The deletions observed on 7q33 are not likely the singular cause of PHACE syndrome; however, it is possible that this region provides a genetic susceptibility to phenotypic expression with other confounding genetic or environmental factors.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22544659      PMCID: PMC3356486          DOI: 10.1002/ajmg.a.35341

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  19 in total

1.  Decline in neurophysiological function after 7 years in an adolescent diabetic cohort and the role of aldose reductase gene polymorphisms.

Authors:  Keerthi Thamotharampillai; Albert K F Chan; Bruce Bennetts; Maria E Craig; Janine Cusumano; Martin Silink; Peter J Oates; Kim C Donaghue
Journal:  Diabetes Care       Date:  2006-09       Impact factor: 19.112

Review 2.  Phenotypic variability and genetic susceptibility to genomic disorders.

Authors:  Santhosh Girirajan; Evan E Eichler
Journal:  Hum Mol Genet       Date:  2010-08-31       Impact factor: 6.150

3.  The human solute carrier gene SLC35B4 encodes a bifunctional nucleotide sugar transporter with specificity for UDP-xylose and UDP-N-acetylglucosamine.

Authors:  Angel Ashikov; Françoise Routier; Jutta Fuhlrott; Yvonne Helmus; Martin Wild; Rita Gerardy-Schahn; Hans Bakker
Journal:  J Biol Chem       Date:  2005-05-23       Impact factor: 5.157

4.  A gene atlas of the mouse and human protein-encoding transcriptomes.

Authors:  Andrew I Su; Tim Wiltshire; Serge Batalov; Hilmar Lapp; Keith A Ching; David Block; Jie Zhang; Richard Soden; Mimi Hayakawa; Gabriel Kreiman; Michael P Cooke; John R Walker; John B Hogenesch
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-09       Impact factor: 11.205

5.  Vascular and nonvascular intracranial malformation associated with external capillary hemangiomas.

Authors:  I Pascual-Castroviejo
Journal:  Neuroradiology       Date:  1978       Impact factor: 2.804

6.  Association between (AC)n dinucleotide repeat polymorphism at the 5'-end of the aldose reductase gene and diabetic nephropathy: a meta-analysis.

Authors:  Mingtong Xu; Xiaochao Chen; Li Yan; Hua Cheng; Weiqing Chen
Journal:  J Mol Endocrinol       Date:  2008-05       Impact factor: 5.098

7.  PHACE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities.

Authors:  I J Frieden; V Reese; D Cohen
Journal:  Arch Dermatol       Date:  1996-03

Review 8.  Missing heritability and strategies for finding the underlying causes of complex disease.

Authors:  Evan E Eichler; Jonathan Flint; Greg Gibson; Augustine Kong; Suzanne M Leal; Jason H Moore; Joseph H Nadeau
Journal:  Nat Rev Genet       Date:  2010-06       Impact factor: 53.242

9.  The UCSC Genome Browser database: update 2011.

Authors:  Pauline A Fujita; Brooke Rhead; Ann S Zweig; Angie S Hinrichs; Donna Karolchik; Melissa S Cline; Mary Goldman; Galt P Barber; Hiram Clawson; Antonio Coelho; Mark Diekhans; Timothy R Dreszer; Belinda M Giardine; Rachel A Harte; Jennifer Hillman-Jackson; Fan Hsu; Vanessa Kirkup; Robert M Kuhn; Katrina Learned; Chin H Li; Laurence R Meyer; Andy Pohl; Brian J Raney; Kate R Rosenbloom; Kayla E Smith; David Haussler; W James Kent
Journal:  Nucleic Acids Res       Date:  2010-10-18       Impact factor: 16.971

10.  BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources.

Authors:  Chunlei Wu; Camilo Orozco; Jason Boyer; Marc Leglise; James Goodale; Serge Batalov; Christopher L Hodge; James Haase; Jeff Janes; Jon W Huss; Andrew I Su
Journal:  Genome Biol       Date:  2009-11-17       Impact factor: 13.583

View more
  5 in total

Review 1.  PHACES syndrome associated with carcinoid endobronchial tumor.

Authors:  Nadia Mama; Dorra H'mida; Imen Lahmar; Mohamed Tahar Yacoubi; Kalthoum Tlili-Graiess
Journal:  Pediatr Radiol       Date:  2013-12-13

2.  The contribution of 7q33 copy number variations for intellectual disability.

Authors:  Fátima Lopes; Fátima Torres; Sally Ann Lynch; Arminda Jorge; Susana Sousa; João Silva; Paula Rendeiro; Purificação Tavares; Ana Maria Fortuna; Patrícia Maciel
Journal:  Neurogenetics       Date:  2017-12-19       Impact factor: 2.660

3.  Prenatal Risk Factors for PHACE Syndrome: A Study Using the PHACE Syndrome International Clinical Registry and Genetic Repository.

Authors:  Joy Wan; Jack Steiner; Eulalia Baselga; Francine Blei; Maria Cordisco; Maria C Garzon; Deborah S Goddard; Anita Haggstrom; Alfons Krol; Ilona J Frieden; Denise Metry; Kimberly D Morel; Judith M A Verhagen; Orli Wargon; Beth A Drolet; Dawn H Siegel
Journal:  J Pediatr       Date:  2017-09-01       Impact factor: 4.406

4.  Arterial Spin-Labeling Perfusion for PHACE Syndrome.

Authors:  M D Mamlouk; A Vossough; L Caschera; M Maheshwari; C P Hess
Journal:  AJNR Am J Neuroradiol       Date:  2020-11-19       Impact factor: 3.825

Review 5.  Genetic investigation of childhood vascular tumor biology reveals pathways for therapeutic intervention.

Authors:  Shayan Cheraghlou; Young Lim; Keith Choate
Journal:  F1000Res       Date:  2019-04-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.